Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
08/2002
08/01/2002US20020103183 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example
08/01/2002US20020103101 Useful in the manufacture of bleach activators such as sodium nonanamidohexanoyloxybenzenesulfonate, possessing improved coloration
08/01/2002CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002CA2429353A1 Lfa-1 antagonist compounds
07/2002
07/31/2002EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain
07/31/2002EP1226113A1 Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors
07/31/2002EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands
07/31/2002EP1226111A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same
07/31/2002EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
07/31/2002EP1226107A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
07/31/2002EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP1225883A1 Anti-ischemic compounds
07/31/2002EP1042310B1 Method for the preparation of citalopram
07/31/2002EP0984972B1 Chiral phosphorus-based ligands
07/31/2002EP0719267B1 Second messenger cell signaling inhibitors
07/31/2002CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
07/31/2002CN1360890A Use of active retiene derivative with negative hormone and/or antagonist
07/30/2002US6426435 Hair, skin and fabric care compositions; water soluble ultraviolet radiation absorbers
07/25/2002WO2002057278A1 Ligands and their use
07/25/2002WO2002057217A2 Method for producing acyl amino acids
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
07/25/2002WO2002057201A2 Polymerizable higher diamondoid derivatives
07/25/2002WO2002056681A2 Novel intermediates and process to pyrimidinedione herbicides
07/25/2002WO2001092205A3 Stabilization of amido acids with antioxidants
07/25/2002US20020099213 Dissolving 6-hydroxy-3,4-dihydroquinolinone and a base in water; dissolving a 1-cyclohexyl-5- (4-halobutyl)-tetrazole in water-immiscible solvent, mixing aqueous phase and organic phase in presence of phase transfer catalyst; recovering
07/25/2002US20020099165 Production process for product of dehydration reaction and apparatus used for the production
07/25/2002US20020099092 For therapy of neurological conditions, e.g. epilepsy and pain
07/25/2002US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
07/25/2002US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
07/25/2002US20020098152 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
07/25/2002DE10142469A1 Production of acylamino acids, useful in cosmetic products such as wash, rinse and cleaning agents, comprises reaction of an amino acid and an alkali source, prepared with a fatty acid halide
07/25/2002CA2434921A1 Polymerizable higher diamondoid derivatives
07/25/2002CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
07/24/2002EP1225166A1 Process for the preparation of enantiomer-enriched beta-amino acids
07/24/2002EP1224163A1 Use of carbonylamino derivatives against cns disorders
07/24/2002EP0989114B1 N,n-disubstituted amic acid derivatives
07/24/2002EP0946495B1 Phenyl acetamides as spla2 inhibitors
07/24/2002EP0882701B1 Substituted amide derivatives
07/23/2002US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same
07/23/2002US6423865 Compounds and their application as well as a method of producing liquid crystalline polymers therefrom
07/23/2002US6423855 Prevention lysis; oxidation resistance
07/23/2002US6423753 Controlling angiogenesis
07/23/2002US6423752 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity
07/23/2002US6423740 Chalcones having antiproliferative activity
07/23/2002US6423733 Fungicidal mixtures
07/18/2002WO2002055483A1 Method of friedel-crafts acylation of anilides
07/18/2002WO2002055454A2 Process and product
07/18/2002WO2002055026A2 Perfluoro sulfonyl halides and related species as polymer support modifiers
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/18/2002WO2001072685A3 Polyamine analogues as cytotoxic agents
07/18/2002WO2001056974A3 Inha inhibitors and their use as antibacterials
07/18/2002US20020095054 Process to produce oxazolidinones
07/18/2002US20020095049 Unsymmetrical bicycloaliphatic chiral diphosphines and phosphine phosphinites, complexes of these compounds with metals of groups VIIb, VIIIb and Ib as hydrogenation catalysts
07/18/2002US20020095040 From 1,2-epoxides; useful as inhibitors of viral or bacterial neuraminidases
07/18/2002US20020094938 Unsaturated phenolic compound forms an amide bond with amine of fragrance; 2-(2,4-dimethylcyclohex-3-en-1-yl),3-(2-(2,4 -dihydroxyphenyl)ethenylcarbonyl)oxazolidine for example; laundry detergents, shampoos and hair conditioners
07/18/2002DE10100971A1 Preparation of N-acyl-beta-amino-acid, for conversion to beta-amino-acid used e.g. in bioactive substance synthesis, uses bis(diorganylphosphino) compound in catalytic hydrogenation of N-acyl-beta-amino-acrylic acid in polar solvent
07/18/2002CA2776023A1 Fumaric acid amides
07/18/2002CA2434570A1 Perfluoro sulfonyl halides and related species as polymer support modifiers
07/17/2002EP1222163A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
07/17/2002EP1039902A4 Inhibitors of gap junction communication
07/17/2002EP0963195B1 Compositions containing an antifungal and a cationic agent
07/17/2002EP0863753B1 Use of perfluoroalkyl derivatives of amino acids as metallo-beta-lactamase inhibitors
07/17/2002CN1087725C Enhancement of the effect of drugs by deuteration
07/16/2002US6420604 Process for the acylation of amino alcohols
07/16/2002US6420600 Hydroxyalkylphenyldiamides
07/16/2002US6420588 Reaction of phenol with phosgene and phase transfer agent
07/16/2002US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury
07/16/2002US6420424 CCR-3 receptor antagonists
07/16/2002US6420390 Heteroarylpiperidines and their use as antipsychotics
07/11/2002WO2002053537A1 Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
07/11/2002WO2002053523A1 Tropolone derivative
07/11/2002WO2002026750A3 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/11/2002WO2002026705A3 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/11/2002WO2002026695A3 Preparation of enantiomerically-enriched cyclopropylalanine derivatives
07/11/2002US20020091274 Taxane derivatives having an amino substituted C13 side chain useful as antileukemia and antitumor agents
07/11/2002US20020091262 Armoatic or heteroarmoatic compound containing substituted amides or thioamides
07/11/2002US20020091210 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen
07/11/2002US20020091150 Carbamic acid derivatives
07/11/2002US20020088146 Composite ski boot
07/11/2002CA2433605A1 Process for preparing (.plusmn.) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
07/11/2002CA2432409A1 Tropolone derivative
07/10/2002EP1220841A2 Trifluoromethyl-substituted spirocyclic ketoenols
07/10/2002EP1220832A1 Novel aromatic compounds
07/10/2002EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
07/10/2002EP0784617B1 Substituted diphenyl oxazolines
07/10/2002CN1357537A Chiral compound (S)-(+)- and (R)-(-)-3-alkylamido-3-carboxy-1-phenyl propanone and prep. thereof
07/10/2002CN1357536A Linking molecule for selective metallation of nucleic acid and its application
07/09/2002US6417399 Ethylation of isoleucine to 3-methylvaleric acid; haloacylation to methyl valeroyl chloride; carboxylation to valnoctic acid; amidation to valnoctamide; antiepileptic agents; psychological disorders
07/09/2002US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents
07/09/2002US6417375 Furylphosphines and organometallic complexes containing them
07/09/2002US6417370 Arylphenyl-substituted cyclic keto-enols
07/09/2002US6417361 Fluorination agent and preparation and use of same
07/09/2002US6417221 Tropane analogs and methods for inhibition of monoamine transport
07/09/2002US6417178 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
07/09/2002US6416921 Forming non-spherical toner particles using limited coalescense; improved transfer and cleaning efficiency
07/09/2002CA2091343C Process for preparing formoterol and related compounds